Intrinsiqq
Corbus Pharmaceuticals Holdings, Inc. logo

Corbus Pharmaceuticals Holdings, Inc. Insider Trading

CRBP

Compare
Last 12 months

Insiders bought 126K and sold 629K on the open market.

84% of the selling was scheduled in advance under 10b5-1 plans.

Net open-market
−502K
2 buys · 12 sales
Under a 10b5-1 plan
84%
of the value sold
Insiders who bought / sold
1 / 8
executives and directors
Last open-market buy
Aug 2026
Aug 11, 2026

Get an email when CRBP's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Oct 29No plan
    Cormorant Asset Management, LP
    Large holder · sold 425,000 at $4.10
    $1.74M
    18% of stake
  • Sep 1410b5-1 plan
    Yong Ben
    Director · sold 2,000 at $7.84
    16K
    18% of stake
  • Aug 11
    Nishant C Saxena
    Chief Business Officer · bought 2,600 at $9.63
    25K
    3.5% of stake
  • Aug 710b5-1 plan
    Yuval Cohen
    Chief Executive Officer · sold 17,000 at $10.08
    171K
    9.8% of stake
  • Aug 710b5-1 plan
    Sean F. Moran
    Chief Financial Officer · sold 12,000 at $10.08
    121K
    12% of stake
  • Jun 1010b5-1 plan
    Winston Kung
    Director · sold 2,026 at $7.91
    16K
    14% of stake
  • Jun 1010b5-1 plan
    John Kenneth Jenkins
    Director · sold 4,800 at $7.91
    38K
    56% of stake
  • Jun 1010b5-1 plan
    Anne Altmeyer
    Director · sold 2,412 at $7.91
    19K
    24% of stake
  • Jun 2 – 3
    Nishant C Saxena
    Chief Business Officer · bought 13,500 at avg $7.50
    101K
    22% of stake
  • Mar 2No plan
    Dominic Smethurst
    Chief Medical Officer · sold 6,097 at $8.30
    51K
    6.4% of stake
  • Feb 17No plan
    Ian Hodgson
    Chief Operating Officer · sold 847 at $7.38
    6K
    1.6% of stake
  • Feb 1310b5-1 plan
    Sean F. Moran
    Chief Financial Officer · sold 4,701 at $7.78
    37K
    4.6% of stake
  • Feb 1310b5-1 plan
    Yuval Cohen
    Chief Executive Officer · sold 13,871 at $7.78
    108K
    7.4% of stake
  • Feb 3No plan
    Dominic Smethurst
    Chief Medical Officer · sold 3,285 at $8.09
    27K
    3.3% of stake
  • Feb 3No plan
    Ian Hodgson
    Chief Operating Officer · sold 2,415 at $8.09
    20K
    4.4% of stake
  • Dec 11, 2025No plan
    Bihua Chen
    Large holder · sold 30,029 at $11.46
    344K
    1.3% of stake
  • Oct 24, 2025 – Oct 27, 202510b5-1 plan
    Yuval Cohen
    Chief Executive Officer · sold 27,633 at avg $17.05
    471K
    17% of stake
  • Oct 24, 202510b5-1 plan
    Sean F. Moran
    Chief Financial Officer · sold 12,981 at $17.02
    221K
    15% of stake
  • Oct 20, 202510b5-1 plan
    Anne Altmeyer
    Director · sold 1,060 at $20.50
    22K
    15% of stake
  • May 30, 202510b5-1 plan
    John Kenneth Jenkins
    Director · sold 2,783 at $7.35
    20K
    37% of stake
  • May 30, 202510b5-1 plan
    Anne Altmeyer
    Director · sold 1,392 at $7.25
    10K
    18% of stake
  • Mar 6, 2025No plan
    Dominic Smethurst
    Chief Medical Officer · sold 6,393 at $6.78
    43K
    8.3% of stake
  • Feb 14, 202510b5-1 plan
    Sean F. Moran
    Chief Financial Officer · sold 2,792 at $8.76
    24K
    3.7% of stake
  • Feb 14, 202510b5-1 plan
    Yuval Cohen
    Chief Executive Officer · sold 7,134 at $8.76
    62K
    4.9% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch CRBP, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with CRBP

CompareIntrinsic value
SYRESpyre Therapeutics, Inc.
$93.47-4.26%10
RFLRafael Holdings Inc.
$0.92+2.21%40
NGNENeurogene Inc.
$22.15-3.40%10
SCNXScienture Holdings Inc.
$2.28-6.45%0
STTKShattuck Labs Inc.
$4.46-1.98%25
TERNTerns Pharmaceuticals, Inc.
$0.00+0.00%10
BTAIBioXcel Therapeutics, Inc.
No recent price30
ORGSOrgenesis Inc.
$0.26-19.71%20

Held by ETFs

CRBP is in 1 US ETF. The largest of them, with CRBP's weight in each:

Spot a number that looks wrong? Check it in CRBP's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing CRBP

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.